Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
Structural and molecular dynamics insights into the competitive inhibition of the platelet-activating factor receptor
Shao-Chi Hung1, Chih-Chieh Chen2, Hua-Chen Chan3
1Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
Abstract:
Platelet-activating factor (PAF) promotes cellular activation, inflammation, and platelet aggregation, leading to acute thrombosis. The remodeling pathway swiftly produces PAF upon activation, establishing intracellular signaling via the PAF receptor (PAFR). Alkyl-PAF exhibits the aforementioned inflammatory properties; conversely, its structural analog acyl-PAF elicits a diminished response and functions as an endogenous PAFR antagonist. The underlying mechanism remains undefined. We conducted the molecular dynamics simulation to elucidate the interactions of acyl-PAF or alkyl-PAF on PAFR. Results showed that alkyl-PAF and acyl-PAF share the same binding pocket. However, acyl-PAF increases the radius of gyration and root-mean-square deviation of PAFR, resulting in structural instability. Root-mean-square fluctuation and solvent-accessible surface area analysis indicated that acyl-PAF reduces flexibility at the PAFR-G protein interface and interaction with key residues involved in signaling, suggesting impaired G protein dissociation and downstream transduction. Acyl-PAF forms stronger interaction with PAFR by increasing hydrogen bonds and favorable Gibbs free energy (ΔG) changes. The Markov state model analysis confirmed these findings, showing that acyl-PAF attaches to PAFR with a lower equilibrium dissociation constant, greater association rate, and lower dissociation rate. In conclusion, acyl-PAF induces structural instability and diminishes signaling effectiveness despite a high binding affinity. This study dissects the intricate interactions within PAFR signaling pathway and offers new insights into potential therapeutic interventions.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...

